Alcidion Group Limited ( (AU:ALC) ) has issued an announcement.
Alcidion Group Limited announced that its Managing Director and CEO, Kate Quirke, has sold 5 million shares to diversify her family’s assets. Despite this sale, Quirke remains committed to Alcidion, retaining approximately 43.6 million shares and expressing confidence in the company’s future growth and profitability, as evidenced by the positive financial outlook for FY25.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through innovative technology solutions that enhance patient care efficiency and quality globally. Their flagship product, Miya Precision, supports clinical decision-making and operational management in healthcare settings. Alcidion has expanded its presence in the UK, Australia, and New Zealand, servicing over 400 hospitals and 87 healthcare organizations, with plans for further geographical expansion.
YTD Price Performance: 50.0%
Average Trading Volume: 1,619,391
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$120.9M
See more insights into ALC stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com